⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

BSX

Boston Scientific Corporation

Healthcare · Medical Devices

45.69USD

-0.3200 (-0.70%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on BSX.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 45.69
P/E18.0
Dvd Ind Yld0.0%
P/B2.66
P/S3.2
Curr EV/T12M EBITDA14.7
Mkt Cap (USD)66.2B
Curr EV (USD)78.5B
2)

Per Share Data

EPS T12M2.47
DPS0.00
Bk Val Per Sh17.23
Rev/Sh14.24
Cash/Sh0.37
Curr Shares Out1,449.2M
FCF/Sh2.46
3)

Cash Flow Analysis

P/CF14.6
Curr P/FCF18.3
CF/NI1.2
Dvd P/O0.0%
Cash Gen/Cash Reqd5.0
Csh Dvd Cov—
CFO/Sales21.6%
Eff Interest Rate33.2%
4)

Growth Potential

Dil EPS 1Y Gr55.2%
Cap 1Y Gr4.2%
BPS 1Y Gr10.7%
R&D To Sales—
Retention Rate100.0%
Rev 1Y Gr19.9%
FCF 1Y Gr38.3%
Assets 1Y Gr10.9%
5)

Profitability

EBITDA5.3B
EBIT4.2B
Operating Margin19.8%
Pretax Margin18.4%
Net Margin17.5%
ROA8.5%
ROE15.5%
ROC12.5%
Asset Turnover0.48
6)

Structure

Current Ratio1.24
Quick Ratio0.56
Debt/Assets14.4%
Debt/Com Eq26.1%
Net Debt/EBITDA1.12
Tot Debt/Capital20.7%
Gross Margin69.9%
EBIT/Int Exp11.4

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.